A detailed history of Yelin Lapidot Holdings Management Ltd. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Yelin Lapidot Holdings Management Ltd. holds 108,377 shares of SNDX stock, worth $1.38 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
108,377
Previous 114,530 5.37%
Holding current value
$1.38 Million
Previous $2.35 Billion 11.27%
% of portfolio
0.34%
Previous 0.41%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$17.93 - $24.81 $110,323 - $152,655
-6,153 Reduced 5.37%
108,377 $2.09 Billion
Q3 2023

Oct 30, 2023

BUY
$14.52 - $21.77 $1.66 Million - $2.49 Million
114,530 New
114,530 $1.66 Billion

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $722M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Yelin Lapidot Holdings Management Ltd. Portfolio

Follow Yelin Lapidot Holdings Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yelin Lapidot Holdings Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Yelin Lapidot Holdings Management Ltd. with notifications on news.